Nasal septal perforation associated with topical corticosteroid therapy.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005260:Female; D005446:Fluocinolone Acetonide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D009300:Nasal Septum / Q000293:injuries*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D014456:Ulcer / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D005446:Fluocinolone Acetonide; C007734:flunisolide